153 related articles for article (PubMed ID: 30849064)
1. Commentary: Aripiprazole: The Second Wave of the Second-generation Antipsychotics.
Kahn DA
J Psychiatr Pract; 2019 Mar; 25(2):146-147. PubMed ID: 30849064
[TBL] [Abstract][Full Text] [Related]
2. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
3. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
Dias Alves M; Micoulaud-Franchi JA; Simon N; Vion-Dury J
J Clin Psychopharmacol; 2018 Dec; 38(6):555-562. PubMed ID: 30247179
[TBL] [Abstract][Full Text] [Related]
4. [Aripiprazole as dopamine partial agonist model: Basic concepts and clinical impact].
Simon N; Azorin JM
Encephale; 2018 Dec; 44(6):558-564. PubMed ID: 30466778
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole.
Prommer E
Am J Hosp Palliat Care; 2017 Mar; 34(2):180-185. PubMed ID: 26589880
[TBL] [Abstract][Full Text] [Related]
8. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, "Goldilocks" actions at dopamine receptors.
Stahl SM
J Clin Psychiatry; 2001 Nov; 62(11):841-2. PubMed ID: 11775041
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients.
Centorrino F; Fogarty KV; Cimbolli P; Salvatore P; Thompson TA; Sani G; Cincotta SL; Baldessarini RJ
J Psychiatr Pract; 2005 Jul; 11(4):241-7. PubMed ID: 16041234
[TBL] [Abstract][Full Text] [Related]
10. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
11. [Aripiprazole, gambling disorder and compulsive sexuality].
Mété D; Dafreville C; Paitel V; Wind P
Encephale; 2016 Jun; 42(3):281-3. PubMed ID: 26923999
[TBL] [Abstract][Full Text] [Related]
12. Clinical evolution of patients treated with aripiprazole long-acting injectable: a preliminary, prospective, observational study.
García Álvarez JC; González Sánchez L; García Resa E; Bonete Llácer JM; Román Rodríguez A; Pecino Esquerdo B; Pérez Martínez E
Int J Psychiatry Clin Pract; 2020 Mar; 24(1):10-17. PubMed ID: 31933402
[No Abstract] [Full Text] [Related]
13. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept Studies.
Macaluso M; Flynn A; Preskorn S
J Psychiatr Pract; 2016 Jan; 22(1):42-9. PubMed ID: 26813487
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs.
Wang LJ; Ree SC; Huang YS; Hsiao CC; Chen CK
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():260-6. PubMed ID: 23085073
[TBL] [Abstract][Full Text] [Related]
15. Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells.
Stapel B; Sieve I; Falk CS; Bleich S; Hilfiker-Kleiner D; Kahl KG
J Psychiatr Res; 2018 Oct; 105():95-102. PubMed ID: 30216787
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of brexpiprazole: comparison with aripiprazole.
Stahl SM
CNS Spectr; 2016 Feb; 21(1):1-6. PubMed ID: 26899451
[TBL] [Abstract][Full Text] [Related]
17. Dramatic Weight Loss Following Addition of Aripiprazole to Olanzapine in a Patient With Treatment-resistant Schizophrenia: A Case Report.
Boland X; Chhabra P
J Psychiatr Pract; 2019 Mar; 25(2):135-138. PubMed ID: 30849062
[TBL] [Abstract][Full Text] [Related]
18. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
Johnsen E; Kroken RA; Løberg EM; Rettenbacher M; Joa I; Larsen TK; Reitan SK; Walla B; Alisauskiene R; Anda LG; Bartz-Johannessen C; Berle JØ; Bjarke J; Fathian F; Hugdahl K; Kjelby E; Sinkeviciute I; Skrede S; Stabell L; Steen VM; Fleischhacker WW
Lancet Psychiatry; 2020 Nov; 7(11):945-954. PubMed ID: 33069317
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole for the treatment of delusional disorders: A systematic review.
Miola A; Salvati B; Sambataro F; Toffanin T
Gen Hosp Psychiatry; 2020; 66():34-43. PubMed ID: 32650190
[TBL] [Abstract][Full Text] [Related]
20. The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents.
Nesvåg R; Bramness JG; Handal M; Hartz I; Hjellvik V; Skurtveit S
Eur Psychiatry; 2018 Mar; 49():16-22. PubMed ID: 29366845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
